ABBV-101
- Generic Name
- ABBV-101
A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 16
- Registration Number
- NCT06887010
- Locations
- 🇺🇸
Acpru /Id# 275921, Grayslake, Illinois, United States
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 244
- Registration Number
- NCT05753501
- Locations
- 🇮🇹
A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 253530, Torino, Piemonte, Italy
🇺🇸Arizona Oncology Associates, PC-HOPE /ID# 252351, Tempe, Arizona, United States
🇬🇧University College London Hospital /ID# 260202, London, Greater London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath